CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Trial Evaluating the Safety and Efficacy of Plerixafor and Sargramostim (GM-CSF) for the Mobilization of Peripheral Blood Stem Cells (PBSC) From Normal, HLA-Matched Allogeneic Sibling Donors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01158118
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:32.991112+00:00
Published At: 2017-05-03T00:00:00+00:00
Record Updated At: 2017-06-05
Results Posted At: 2017-05-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Leukemia, Myeloid, Acute", "Myelodysplastic Syndromes", "Lymphoma, Non-Hodgkin", "Hodgkin Disease", "Leukemia, Lymphocytic, Chronic, B-Cell", "Multiple Myeloma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-06-05"
protocolSection.identificationModule.nctId: "NCT01158118"
protocolSection.identificationModule.officialTitle: "A Phase II Trial Evaluating the Safety and Efficacy of Plerixafor and Sargramostim (GM-CSF) for the Mobilization of Peripheral Blood Stem Cells (PBSC) From Normal, HLA-Matched Allogeneic Sibling Donors"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-05-03"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.